APEXIAN PHARMACEUTICALS
Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking work on APE1/Ref-1 redox protein signaling at the Indiana University School of Medicine has provided a unique insight into this novel biological target. It was founded in 2005 and headquartered in Indianapolis, Indiana.
APEXIAN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.apexianpharma.com
Total Employee:
1+
Status:
Active
Contact:
(317) 684-9106
Email Addresses:
[email protected]
Total Funding:
6.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Investors List
IU Ventures
IU Ventures investment in Venture Round - Apexian Pharmaceuticals
Elevate Ventures
Elevate Ventures investment in Series A - Apexian Pharmaceuticals
BioCrossroads
BioCrossroads investment in Venture Round - Apexian Pharmaceuticals
IU Ventures
IU Ventures investment in Seed Round - Apexian Pharmaceuticals
Official Site Inspections
http://www.apexianpharma.com
- Host name: cloudproxy10107.sucuri.net
- IP address: 192.124.249.107
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
